Sun Pharma to acquire Organon in USD 11.75 billion deal
Sun Pharma→Organon
Apr 28, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Astorg has acquired Thermo Fisher Scientific Microbiology Business - Clinical Lab Products, a diagnostics imaging business in the healthcare sector. The Thermo Fisher Scientific Microbiology Business - Clinical Lab Products provides clinical laboratory microbiology solutions used for pathogen detection and related testing workflows. Astorg acquisitions in diagnostics imaging acquisition focus on strengthening healthcare M&A capabilities in clinical lab products and expanding private equity acquisition exposure to diagnostics demand. This divestiture acquisition is an announced healthcare M&A transaction by a private equity buyer, with deal size undisclosed and terms not publicly specified.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
Apr 28, 2026
Sun Pharma→Organon
Apr 28, 2026
IMG Pharma→Matsumoto Pharmaceutical
Apr 27, 2026
TPG→Optum UK
Apr 27, 2026
Sun Pharma→Organon
Apr 27, 2026